Author

Malcolm Anders Smith

National Institutes of HealthORCID 0000-0001-9880-9876Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Assay:whole-genome sequencing· 2

Frequent Co-Authors

Apexa ModiiD· 3 shared John M. MarisiD· 3 shared Komal S. RathiiD· 3 shared Sharon J. DiskiniD· 3 shared Gonzalo LópeziD· 2 shared Jo Lynne RokitaiD· 2 shared Karina L. ConkriteiD· 2 shared Kateryna KrytskaiD· 2 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenomics

Apexa ModiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancer CellPeer-reviewedOct 24, 2024

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma

Amber K. Weiner, Alexander B. Radaoui, Matthew Tsang…·Sharon J. Diskin

This study identifies DLK1 as a potential immunotherapeutic target in neuroblastoma through integrative proteomic, transcriptomic, and epigenomic analysis.

28 citationstop 3%

humanproteomics

𝕏 PostBluesky

GenomicsGenome ResearchPeer-reviewedSep 1, 2020

Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma

Gonzalo López, Karina L. Conkrite, Miriam Doepner…·Sharon J. Diskin

This study identifies somatic structural variations in neuroblastoma, showing their enrichment in neurodevelopmental genes and the tumor suppressor role of SHANK2.

33 citations

humanwhole-genome sequencing

𝕏 PostBluesky

GenomicsCell ReportsPeer-reviewedNov 1, 2019

Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design

Jo Lynne Rokita, Komal S. Rathi, Maria Cardenas…·John M. Maris

This paper genomically characterizes 261 pediatric cancer patient-derived xenograft models to guide rational clinical trial design and drug development.

173 citationstop 1%

humanwhole-genome sequencing

𝕏 PostBluesky